Maria C. Ochoa

Pamplona, NC, Spain

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 46 publications

Author Correction: Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy.

Author Correction: Prophylactic TNF blockade uncouples efficacy and toxicity in dual CTLA-4 and PD-1 immunotherapy.

Journal: Nature
Published: October 01, 2025

A Phase II Study of Perioperative Avelumab plus Chemotherapy for Patients with Resectable Gastric Cancer or Gastroesophageal Junction Cancer - The MONEO Study.

A Phase II Study of Perioperative Avelumab plus Chemotherapy for Patients with Resectable Gastric Cancer or Gastroesophageal Junction Cancer - The MONEO Study.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: January 31, 2025

Targeting the CD40 costimulatory receptor to improve virotherapy efficacy in diffuse midline gliomas.

Targeting the CD40 costimulatory receptor to improve virotherapy efficacy in diffuse midline gliomas.

Journal: Cell reports. Medicine
Published: October 08, 2024

The oncolytic adenovirus Delta-24-RGD in combination with ONC201 induces a potent antitumor response in pediatric high-grade and diffuse midline glioma models.

The oncolytic adenovirus Delta-24-RGD in combination with ONC201 induces a potent antitumor response in pediatric high-grade and diffuse midline glioma models.

Journal: Neuro-oncology
Published: March 30, 2024

Low-Dose Ionizing γ-Radiation Elicits the Extrusion of Neutrophil Extracellular Traps.

Low-Dose Ionizing γ-Radiation Elicits the Extrusion of Neutrophil Extracellular Traps.

Journal: Clinical cancer research : an official journal of the American Association for Cancer Research
Published: December 09, 2023

CD137 (4-1BB) requires physically associated cIAPs for signal transduction and antitumor effects.

CD137 (4-1BB) requires physically associated cIAPs for signal transduction and antitumor effects.

Journal: Science advances
Published: August 18, 2023

Intratumoral neoadjuvant immunotherapy based on the BO-112 viral RNA mimetic.

Intratumoral neoadjuvant immunotherapy based on the BO-112 viral RNA mimetic.

Journal: Oncoimmunology
Published: April 10, 2023

Intratumoral co-injection of NK cells and NKG2A-neutralizing monoclonal antibodies.

Intratumoral co-injection of NK cells and NKG2A-neutralizing monoclonal antibodies.

Journal: EMBO molecular medicine
Published: April 04, 2023

Intratumoral immunotherapy with mRNAs encoding chimeric protein constructs encompassing IL-12, CD137 agonists, and TGF-β antagonists.

Intratumoral immunotherapy with mRNAs encoding chimeric protein constructs encompassing IL-12, CD137 agonists, and TGF-β antagonists.

Journal: Molecular therapy. Nucleic acids
Published: January 11, 2023

Synergistic effects of combined immunotherapy strategies in a model of multifocal hepatocellular carcinoma.

Synergistic effects of combined immunotherapy strategies in a model of multifocal hepatocellular carcinoma.

Journal: Cell reports. Medicine
Published: September 16, 2022

Killers on the loose: Immunotherapeutic strategies to improve NK cell-based therapy for cancer treatment.

Killers on the loose: Immunotherapeutic strategies to improve NK cell-based therapy for cancer treatment.

Journal: International review of cell and molecular biology
Published: July 07, 2022

Soluble CD137 as a dynamic biomarker to monitor agonist CD137 immunotherapies.

Soluble CD137 as a dynamic biomarker to monitor agonist CD137 immunotherapies.

Journal: Journal for immunotherapy of cancer
Published: January 12, 2022
Showing 1-12 of 46

Last Updated: 09/26/2026